Heikkinen, J
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
a 2025 literature-and-patent review in Pharmaceuticals summarizes its multifunctional, mostly-preclinical profile (PMC11859134)
KLOW is a high-purity research peptide blend supplied as an 80mg vial with bacteriostatic water, used by laboratories to study peptide signaling, structural protein regulation, and cellular-communication pathways
Retrieved May 6, 2025, from Burick Center
Lead Researcher Spotlight Professor Predrag Sikiric, MD, PhD Department of Pharmacology University of Zagreb School of Medicine, Zagreb, Croatia Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, establishing the foundational research base for one of the key components in KLOW Blend